Published in Am J Rhinol on August 15, 2008
Lifestyle Intervention Treatment for Patients With Mild Obstructive Sleep Apnea | NCT00486746
Effect of a very low energy diet on moderate and severe obstructive sleep apnoea in obese men: a randomised controlled trial. BMJ (2009) 2.06
Effectiveness of lifestyle interventions on obstructive sleep apnea (OSA): systematic review and meta-analysis. Sleep (2013) 1.20
Predictive role of nasal functionality tests in the evaluation of patients before nocturnal polysomnographic recording. Acta Otorhinolaryngol Ital (2011) 0.91
Obstructive sleep apnoea syndrome and weight loss: review. Sleep Disord (2012) 0.79
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med (2004) 17.91
Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet (2006) 11.64
Bariatric surgery and long-term cardiovascular events. JAMA (2012) 7.11
Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med (2012) 6.19
Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol (2009) 5.37
Lifestyle intervention with weight reduction: first-line treatment in mild obstructive sleep apnea. Am J Respir Crit Care Med (2008) 3.80
Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology (2009) 3.67
Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol (2009) 3.14
Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diab Vasc Dis Res (2005) 2.91
Endothelial function is well preserved in obese patients with mild obstructive sleep apnea. Sleep Breath (2013) 2.67
Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D). Diabetes Care (2010) 2.50
Heart rate variability associates with asymptomatic coronary atherosclerosis. Clin Auton Res (2013) 2.12
Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study. Diabetes Care (2008) 1.95
Trends in self-reported sleep duration and insomnia-related symptoms in Finland from 1972 to 2005: a comparative review and re-analysis of Finnish population samples. J Sleep Res (2008) 1.94
National type 2 diabetes prevention programme in Finland: FIN-D2D. Int J Circumpolar Health (2007) 1.92
Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans. Am J Clin Nutr (2012) 1.80
Sleep duration is associated with an increased risk for the prevalence of type 2 diabetes in middle-aged women - The FIN-D2D survey. Sleep Med (2007) 1.78
The impact of history of hypertension and type 2 diabetes at baseline on the incidence of stroke and stroke mortality. Stroke (2005) 1.76
Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study--secondary analysis of the randomized trial. PLoS One (2009) 1.68
Sustained improvement in mild obstructive sleep apnea after a diet- and physical activity-based lifestyle intervention: postinterventional follow-up. Am J Clin Nutr (2010) 1.67
Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes. Diabetes Care (2012) 1.66
Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation (2004) 1.65
Plant sterols in serum and in atherosclerotic plaques of patients undergoing carotid endarterectomy. J Am Coll Cardiol (2005) 1.54
Health care use during 20 years following bariatric surgery. JAMA (2012) 1.52
Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish Diabetes Prevention Study. Diabetes Care (2008) 1.51
Baroreflex sensitivity in essential and secondary hypertension. Clin Auton Res (2002) 1.50
Short-term blood pressure variability in renovascular hypertension and in severe and mild essential hypertension. Clin Sci (Lond) (2003) 1.45
Effects of plant stanol and sterol esters on serum phytosterols in a family with familial hypercholesterolemia including a homozygous subject. J Lab Clin Med (2004) 1.45
Effects of ultrafine and fine particulate and gaseous air pollution on cardiac autonomic control in subjects with coronary artery disease: the ULTRA study. J Expo Sci Environ Epidemiol (2005) 1.42
Cholesterol absorption and synthesis in pediatric kidney, liver, and heart transplant recipients. Transplantation (2006) 1.41
Cholesterol precursors and plant sterols in children with food allergy. Am J Clin Nutr (2003) 1.39
Preoperative alterations in correlation properties and complexity of R-R interval dynamics predict the risk of atrial fibrillation after coronary artery bypass grafting in patients with preserved left ventricular function. J Cardiovasc Electrophysiol (2008) 1.39
Can we identify sources of fine particles responsible for exercise-induced ischemia on days with elevated air pollution? The ULTRA study. Environ Health Perspect (2006) 1.38
Sleep duration, lifestyle intervention, and incidence of type 2 diabetes in impaired glucose tolerance: The Finnish Diabetes Prevention Study. Diabetes Care (2009) 1.34
High expression of complement components in omental adipose tissue in obese men. Obes Res (2003) 1.34
Two year reduction in sleep apnea symptoms and associated diabetes incidence after weight loss in severe obesity. Sleep (2007) 1.33
Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism--the GENOBIN study. PLoS One (2008) 1.31
Associations of chronotype and sleep with cardiovascular diseases and type 2 diabetes. Chronobiol Int (2013) 1.31
Self-reported sleep duration, all-cause mortality, cardiovascular mortality and morbidity in Finland. Sleep Med (2011) 1.30
Lifestyle intervention to prevent diabetes in men and women with impaired glucose tolerance is cost-effective. Int J Technol Assess Health Care (2007) 1.30
Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men. J Lipid Res (2003) 1.27
The common variant in the FTO gene did not modify the effect of lifestyle changes on body weight: the Finnish Diabetes Prevention Study. Obesity (Silver Spring) (2009) 1.26
Maternal preeclampsia predicts elevated blood pressure in 12-year-old children: evaluation by ambulatory blood pressure monitoring. Pediatr Res (2006) 1.22
Silicone tubing is not necessary after primary endoscopic dacryocystorhinostomy: a prospective randomized study. Am J Rhinol (2008) 1.22
Leisure-time physical activity and the metabolic syndrome in the Finnish diabetes prevention study. Diabetes Care (2010) 1.22
High prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish population. BMC Public Health (2008) 1.15
Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey. BMC Public Health (2011) 1.14
Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans. J Hepatol (2011) 1.14
Gallstones, gallbladder disease, and pancreatitis: cross-sectional and 2-year data from the Swedish Obese Subjects (SOS) and SOS reference studies. Am J Gastroenterol (2003) 1.14
Long-term results, late complications and quality of life in a series of adjustable gastric banding. Obes Surg (2004) 1.13
Long-term consistency of diurnal-type preferences among men. Chronobiol Int (2013) 1.13
Serum noncholesterol sterols during inhibition of cholesterol synthesis by statins. J Lab Clin Med (2003) 1.12
Effect of ezetimibe and/or simvastatin on coenzyme Q10 levels in plasma: a randomised trial. Drug Saf (2006) 1.12
Adipose tissue TCF7L2 splicing is regulated by weight loss and associates with glucose and fatty acid metabolism. Diabetes (2012) 1.10
Reducing the risk of type 2 diabetes with nutrition and physical activity - efficacy and implementation of lifestyle interventions in Finland. Public Health Nutr (2010) 1.09
Whole grain products, fish and bilberries alter glucose and lipid metabolism in a randomized, controlled trial: the Sysdimet study. PLoS One (2011) 1.08
Metabolic syndrome and the progression of carotid intima-media thickness in elderly women. Arch Intern Med (2006) 1.08
Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity. J Hepatol (2010) 1.08
Long-term epilepsy surgery outcomes in patients with MRI-negative temporal lobe epilepsy. Epilepsia (2010) 1.07
The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress. Alzheimers Dement (2013) 1.07
Pharmaceutical costs in obese individuals: comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment: the SOS intervention study. Arch Intern Med (2002) 1.06
Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey. BMC Public Health (2010) 1.05
Relation of chronotype to sleep complaints in the general Finnish population. Chronobiol Int (2012) 1.05
Telomere length in circulating leukocytes is associated with lung function and disease. Eur Respir J (2013) 1.04
Bilberries reduce low-grade inflammation in individuals with features of metabolic syndrome. Mol Nutr Food Res (2012) 1.04
Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression: a randomized trial in healthy men. Atherosclerosis (2007) 1.03
The increasing prevalence of metabolic syndrome among Finnish men and women over a decade. J Clin Endocrinol Metab (2007) 1.03
Serum high sensitivity C-reactive protein and cognitive function in elderly women. Age Ageing (2007) 1.03
Cardiometabolic profile of people screened for high risk of type 2 diabetes in a national diabetes prevention programme (FIN-D2D). Prim Care Diabetes (2010) 1.02
Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant. PLoS One (2012) 1.02
Heritability of BMD of femoral neck and lumbar spine: a multivariate twin study of Finnish men. J Bone Miner Res (2007) 1.01
Increased exposure to estrogens disturbs maturation, steroidogenesis, and cholesterol homeostasis via estrogen receptor alpha in adult mouse Leydig cells. Endocrinology (2009) 1.01
Depot-specific expression of fibroblast growth factors in human adipose tissue. Obes Res (2002) 1.01
A dietary and behavioural programme for the treatment of obesity. A 4-year clinical trial and a long-term posttreatment follow-up. J Intern Med (2003) 1.00
C-reactive protein and metabolic syndrome in elderly women: a 12-year follow-up study. Diabetes Care (2006) 0.99
The activation of the inflammatory cytokines in overweight patients with mild obstructive sleep apnoea. J Sleep Res (2009) 0.99
Weight reduction and increased physical activity to prevent the progression of obstructive sleep apnea: A 4-year observational postintervention follow-up of a randomized clinical trial. [corrected]. JAMA Intern Med (2013) 0.99